ETONEton Pharmaceuticals, Inc.
31.26USD-4.07%Mkt Cap: 857.38M USDP/E: Last update: 2026-05-26

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-…

Indicators:|

Key Statistics

Company
Market Cap857.38M USD
Enterprise Value970.33M USD
Revenue (TTM)86.93M USD
Gross Profit42.74M USD
Net Income (TTM)-4.60M USD
Revenue/Share3.219 USD
Last Price31.26 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees44
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN
Valuation
P/E (Trailing)
P/E (Forward)18.62
PEG
EV/EBITDA87.54
EV/Revenue11.16
P/S11.03
P/B36.19
EPS (TTM)-0.06
EPS (Forward)1.88
52W Range
13.0981% of range35.66
52W High35.66 USD
52W Low13.09 USD
Profitability
Gross Margin53.46%
Oper. Margin11.39%
EBITDA Margin12.75%
Profit Margin-5.75%
ROE-17.59%
ROA-4.99%
Growth
Revenue Growth40.40%
Earnings Growth
Cash Flow & Leverage
Operating CF10.52M USD
CapEx (TTM)333.00K USD
FCF Margin2.81%
FCF Yield0.28%
Net Debt11.60M USD
Net Debt/EBITDA1.05
Balance Sheet
Debt/Equity1.19
Current Ratio1.21
Quick Ratio0.75
Book Value/Sh0.9670 USD
Cash/Share0.7180 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)42.67 USD
Target Range31.00 USD57.00 USD
# Analysts3
Ownership
Shares Out.27.39M
Float21.00M
Insiders4.93%
Institutions65.43%
Short Interest
Short Ratio4.3d
Short % Float8.40%
Short % Out.5.97%
Shares Short1.63M
Short (prev mo.)1.89M
Technical
SMA 5025.84 (+21.0%)
SMA 20019.39 (+61.3%)
Beta0.82
S&P 52W Chg28.31%
Avg Vol (30d)400.95K
Avg Vol (10d)402.93K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)